JSA assists sale of DXC’s health services business

DXC technologies health medical tech

J Sagar Associates (JSA) advised New York Stock Exchange-listed DXC Technologies on the India leg of a US$5 billion sale of its US state and local health and human services business to Veritas Capital.

The deal was signed on 10 March and closed on 1 October. Sajai Singh, a partner at JSA who advised on the deal, told India Business Law Journal that it was “an amazing experience to work with teams, literally in every continent, working towards this deadline”.

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.

For group subscribers, please click here to access.
Interested in group subscription? Please contact us.